Loading...
•
Jun 30, 2022
Astrana Health Q2 2022 Earnings Report
ApolloMed's financial performance increased in Q2 2022, with revenue up 54% year-over-year, despite a decrease in net income attributable to ApolloMed.
Key Takeaways
Apollo Medical Holdings, Inc. reported a strong second quarter in 2022, with a 54% increase in total revenue to $269.7 million. However, net income attributable to ApolloMed decreased to $11.4 million, and EPS-diluted was $0.25. The company is reiterating its full-year guidance for total revenue, net income, EBITDA, and Adjusted EBITDA.
Total revenue increased by 54% to $269.7 million compared to the prior-year quarter.
Net income attributable to ApolloMed was $11.4 million, a decrease from $12.7 million in the prior-year quarter.
Earnings per share (diluted) decreased to $0.25 compared to $0.28 in the prior-year quarter.
Adjusted EBITDA increased by 14% to $36.9 million compared to the prior-year quarter.
Forward Guidance
ApolloMed is reiterating its guidance for the year ending December 31, 2022, with total revenue expected to be between $1,055.0 million and $1,085.0 million, net income between $38.0 million and $57.0 million, EBITDA between $81.0 million and $111.0 million, and Adjusted EBITDA between $136.0 million and $166.0 million.
Positive Outlook
- Total revenue between $1,055.0 million and $1,085.0 million.
- Net income between $38.0 million and $57.0 million.
- EBITDA between $81.0 million and $111.0 million.
- Adjusted EBITDA between $136.0 million and $166.0 million.
- Based on the Company’s existing business, current view of existing market conditions and assumptions
Challenges Ahead
- There can be no assurance that actual amounts will not be materially higher or lower than these expectations.
- Guidance is subject to existing market conditions.
- Guidance is based on the company's assumptions.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...